• Like
Lyme disease town meeting dr. beard, cdcp
Upcoming SlideShare
Loading in...5
×

Lyme disease town meeting dr. beard, cdcp

  • 354 views
Uploaded on

 

More in: Education
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
354
On Slideshare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
0
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1.
    • CDC’s National Lyme Disease Prevention Program
    C. Ben Beard, Ph.D. Chief, Bacterial Diseases Branch CDC – Division of Vector-Borne Diseases
  • 2. CDC’s Role with Lyme and Other VBDs
    • Coordinate nation-wide surveillance
    • Provide science-based recommendations for prevention and control
    • Investigate disease outbreaks – both nationally and internationally
    • Serve as a national reference and diagnostic laboratory
    • Conduct multidisciplinary public health-oriented prevention research
    • Provide training for diagnosing, preventing, and investigating VBDs
    • Collaborate with universities, industry, and public health partners in promoting sound disease prevention policies and practices
    CDC serves as the lead federal agency for prevention of Lyme and other Vector-borne diseases (VBDs) in humans. Key program activities include…
  • 3. Top 10 Notifiable Diseases in the U.S., 2008 *Confirmed cases - Total cases = 35,198 Disease Case numbers 1. Chlamydia 1,210,523 2. Gonorrhea 336,742 3. Salmonellosis 51,040 4. Syphillis 46,277 5. AIDS 39,202 6. Varicella 30,386 7. Lyme disease* 28,921 8. Shigellosis 22,625 9. Giardiasis 18,908 10. Pertussis 13,278
  • 4. Lyme Disease in the U.S. – Key Challenges in 2010
    • Increasing case numbers
    • Expanding geographic distribution
    • No ‘magic bullet’ shown to be effective in preventing human cases in large community trials
    • Polarization among key stakeholders (state/federal agencies, advocacy groups, physicians)
  • 5. CDC’s 4-Part Strategy for Preventing Lyme disease
    • Strengthen and refine national surveillance
    • Identify and validate effective prevention methods and approaches
    • Improve early and accurate diagnosis and treatment
    • Leverage collaborative potential for program implementation
  • 6. Strengthen and Refine National Surveillance
    • Work with state DoHs and CSTE to improve Lyme disease reporting and/or to arrive at more efficient and accurate estimates of Lyme disease cases
    • Evaluate the impact of recent case definition changes in on reporting practices and resulting case numbers
    • Establish regional TickNet sites to collect data on underreporting that can be used for determining the accuracy of surveillance estimates
  • 7. Identify and Validate Effective Prevention Methods and Approaches
    • Conduct laboratory and field research on novel approaches for controlling ticks and blocking transmission (ex. RTVs, natural product acaricides, bait boxes, antibiotic baits, deer removal, novel vaccine targets, etc.)
    • Evaluate prevention education messages and develop improved communication plan
    • Evaluate the effectiveness of specific intervention methods and approaches at reducing human illness at TickNet sites
  • 8.
    • Develop, disseminate, and evaluate physician education material for Lyme disease diagnosis and treatment
    • Sponsor and/or conduct research aimed at developing and/or evaluating improved diagnostic tests
    • Procure serum specimens for use in validation of improved diagnostic tests
    Improve Early and Accurate Diagnosis and Treatment
  • 9. Leverage Collaborative Potential for Program Implementation
    • Establish working relationships with key stakeholders who are either current or potential future collaborators on national prevention efforts
    • Conduct road trips, sponsor regional conferences, set up strategic meetings to foster good communication and effective working relationships
    • Work with endemic communities to develop community-wide Lyme disease prevention programs
    • Consult with FDA in the evaluation and approval of improved diagnostic tests
  • 10. FY2010 Key Extramural Program Investments
    • Funding plans…
    • Cooperative agreements evaluating reservoir-targeted vaccines and natural product insecticides
    • 4 regional TickNet sites for surveillance studies and evaluation of intervention methods
    • Assistance to 15 states to aid in Lyme disease surveillance
    • Projects aimed at developing improved diagnostic tests
    • 5-year study looking at long term complications of Lyme disease
    • Local Lyme disease community prevention projects
  • 11. Thank you for your time and attention! The findings and conclusions in this report have not been formally disseminated by the Centers for Disease Control and Prevention and should not be construed to represent any agency determination or policy